ArticleHeliyon2024

Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer.

Francesca Matilde Schipilliti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.